drugset / Trial / NCT03563573

Single-dose Potassium Supplementation in Patients With ADHD for Whom the Anesthetic Lidocaine is Ineffective

NCT03563573 ↗

Phase 1/2 Unknown 100 enrolled AlkaliDx, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Randomized, controlled, double-blind trial of the effect of a single dose of potassium on ADHD symptoms as measured by changes in measures of symptoms of ADHD correlated with the results of their Lidocaine Effectiveness Test.

Timeline

Start
2018-07-01
Primary completion
2018-11-04
Completion
2018-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Potassium Gluconate Small molecule 8 mg/kg Oral
Comparator Potassium Gluconate Small molecule 14 meq Oral